Multiple Choice
Administration of _______ is not likely to lead to a decrease in food intake and thus weight loss.
A) 5-HT1B agonists
B) 5-HT2C agonists
C) 5-HT1A agonists
D) 5-HT6 antagonists
Correct Answer:

Verified
Correct Answer:
Verified
Q14: The 5-HT<sub>6</sub> antagonist _ is being tested
Q15: 5,7-Dihydroxytryptamine (5,7-DHT)<br>A) is a metabolite of serotonin.<br>B)
Q16: Why might increasing levels of tryptophan in
Q17: Researchers study the effects of serotonin depletion
Q18: One brain region implicated in the neural
Q19: Which method(s) can be used to produce
Q20: How do 5-HT<sub>2A</sub> receptors exert their postsynaptic
Q21: Studies using animal models have shown that
Q23: Evidence that serotonergic abnormalities may be involved
Q24: Evidence supporting a link between low levels